Suppression of ventricular fibrillation and positive inotropic action of bethanidine sulfate, a chemical analog of bretylium tosylate that is well absorbed orally
- 31 January 1982
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 49 (1), 45-55
- https://doi.org/10.1016/0002-9149(82)90276-4
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Toward preventing coronary death from ventricular fibrillation.Circulation, 1976
- Prophylactic quinidine for the prevention of arrhythmias after acute myocardial infarctionThe American Journal of Cardiology, 1974
- Epidemiology of Sudden DeathArchives of Internal Medicine, 1972
- TRIAL OF COMBINED INTRAMUSCULAR AND INTRAVENOUS LIGNOCAINE IN PROPHYLAXIS OF VENTRICULAR TACHYARRHYTHMIASThe Lancet, 1972
- Lignocaine Therapy for Ventricular Ectopic Activity after Acute Myocardial Infarction: A Double-blind TrialBMJ, 1971
- Antiarrhythmic drugs in the prevention of ventricular arrhythmias related to paired pacingThe American Journal of Cardiology, 1970
- Bretylium Tosylate for Suppression of Ventricular Fibrillation after Experimental Myocardial InfarctionNature, 1968
- Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylateThe American Journal of Cardiology, 1968
- Quantitative comparison of bretylium with other antifibrillatory drugsThe American Journal of Cardiology, 1968
- Bretylium tosylate for suppression of induced ventricular fibrillationThe American Journal of Cardiology, 1966